haloperidol

Generic: haloperidol

Labeler: creekwood pharmaceuticals llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name haloperidol
Generic Name haloperidol
Labeler creekwood pharmaceuticals llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

haloperidol 5 mg/1

Manufacturer
Creekwood Pharmaceuticals LLC

Identifiers & Regulatory

Product NDC 82619-108
Product ID 82619-108_46d58435-0437-e206-e063-6294a90ae755
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA218162
Listing Expiration 2026-12-31
Marketing Start 2026-01-05

Pharmacologic Class

Established (EPC)
typical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 82619108
Hyphenated Format 82619-108

Supplemental Identifiers

RxCUI
197754 310670 310671 310672 314034 314035
UPC
0382619105018 0382619105025 0382619108033 0382619109023 0382619109016 0382619109030 0382619110029 0382619106022 0382619107029 0382619106015 0382619107012 0382619108026
UNII
J6292F8L3D
NUI
N0000180182

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name haloperidol (source: ndc)
Generic Name haloperidol (source: ndc)
Application Number ANDA218162 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 30 TABLET in 1 BOTTLE (82619-108-01)
  • 100 TABLET in 1 BOTTLE (82619-108-02)
  • 1000 TABLET in 1 BOTTLE (82619-108-03)
source: ndc

Packages (3)

82619-108-01 30 TABLET in 1 BOTTLE (82619-108-01) 82619-108-02 100 TABLET in 1 BOTTLE (82619-108-02) 82619-108-03 1000 TABLET in 1 BOTTLE (82619-108-03)

Ingredients (1)

haloperidol (5 mg/1)

Linked Drug Pages (1)

HALOPERIDOL ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "46d58435-0437-e206-e063-6294a90ae755", "openfda": {"nui": ["N0000180182"], "upc": ["0382619105018", "0382619105025", "0382619108033", "0382619109023", "0382619109016", "0382619109030", "0382619110029", "0382619106022", "0382619107029", "0382619106015", "0382619107012", "0382619108026"], "unii": ["J6292F8L3D"], "rxcui": ["197754", "310670", "310671", "310672", "314034", "314035"], "spl_set_id": ["9763c044-7430-48f7-bf3e-da1c7c683955"], "pharm_class_epc": ["Typical Antipsychotic [EPC]"], "manufacturer_name": ["Creekwood Pharmaceuticals LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (82619-108-01)", "package_ndc": "82619-108-01", "marketing_start_date": "20260105"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (82619-108-02)", "package_ndc": "82619-108-02", "marketing_start_date": "20260105"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (82619-108-03)", "package_ndc": "82619-108-03", "marketing_start_date": "20260105"}], "brand_name": "HALOPERIDOL", "product_id": "82619-108_46d58435-0437-e206-e063-6294a90ae755", "dosage_form": "TABLET", "pharm_class": ["Typical Antipsychotic [EPC]"], "product_ndc": "82619-108", "generic_name": "haloperidol", "labeler_name": "Creekwood Pharmaceuticals LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "HALOPERIDOL", "active_ingredients": [{"name": "HALOPERIDOL", "strength": "5 mg/1"}], "application_number": "ANDA218162", "marketing_category": "ANDA", "marketing_start_date": "20260105", "listing_expiration_date": "20261231"}